All In MedTech

FDA Clearance Tracker · P160042-S010

Revanesse® Lips+

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Sep 21, 2020 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Sep 21, 2020

Approved

Time to decision

357 days

Received Sep 30, 2019. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Panel Track

Device class

Class III

The decision

FDA number
P160042-S010
Device name
Revanesse® Lips+
Applicant location
Aurora
Received
Sep 30, 2019
Decided
Sep 21, 2020
Decision
Approved
Supplement type
Panel Track
Reason for supplement
Labeling Change - Indications/instructions/shelf life/tradename
Original approval
P160042

Device type

Device class
Class III

Every decision under product code LMH

FDA's approval statement

As written in FDA's record.

Approval for the Revanesse® Lips+. The device is indicated for submucosal implantation for lip augmentation in patients 22 years of age or older.

Source documents

Other decisions for Prollenium Medical Technologies, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.